Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
3.870
-0.220 (-5.38%)
At close: Sep 12, 2025, 4:00 PM EDT
3.920
+0.050 (1.28%)
After-hours: Sep 12, 2025, 7:57 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $68.35 million as of September 12, 2025. Its market cap has increased by 103.25% in one year.
Market Cap
68.35M
Enterprise Value
46.43M
1-Year Change
103.25%
Ranking
Category
Stock Price
$3.87
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $68.35M, an increase of 2.80%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 68.35M | -17.09% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |